These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34223708)

  • 1. Sjögren's syndrome complicated with membranous nephropathy, a cause or coincidence?
    Chen R; Wang J; Xie Q; Xue J; Hao C
    Int J Rheum Dis; 2021 Aug; 24(8):1086-1094. PubMed ID: 34223708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating antibodies to α-enolase and phospholipase A
    Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
    Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
    Bobart SA; De Vriese AS; Pawar AS; Zand L; Sethi S; Giesen C; Lieske JC; Fervenza FC
    Kidney Int; 2019 Feb; 95(2):429-438. PubMed ID: 30665573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
    Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
    Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
    Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
    Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
    Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
    Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
    Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sensitivity and Specificity of Serum Phospholipase A2 Receptor Antibodies in Diagnosing Primary Membranous Nephropathy in Patients with Adult Nephrotic Syndrome and its Correlation with Serum Phospholipase A2 Receptor Staining in Kidney Biopsies.
    Vellakampadi D; Bonu R; Siddini V; Vankalakunti M
    Saudi J Kidney Dis Transpl; 2023 Sep; 34(5):416-426. PubMed ID: 38995300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cohort study of membranous nephropathy, primary or secondary.
    Arghiani M; Zamani BH; Nazemian F; Samadi S; Afsharian MS; Habibzadeh M; Eslami S; Sabbagh MG
    BMC Nephrol; 2021 Apr; 22(1):138. PubMed ID: 33874909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
    Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
    Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.
    Burbelo PD; Joshi M; Chaturvedi A; Little DJ; Thurlow JS; Waldman M; Olson SW
    J Am Soc Nephrol; 2020 Jan; 31(1):208-217. PubMed ID: 31843984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-phospholipase A2 receptor antibody in membranous nephropathy.
    Qin W; Beck LH; Zeng C; Chen Z; Li S; Zuo K; Salant DJ; Liu Z
    J Am Soc Nephrol; 2011 Jun; 22(6):1137-43. PubMed ID: 21566055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA; McRae JL; Dwyer KM
    Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
    Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to M-type phospholipase A2 receptor (PLA
    Garcia-Vives E; Solé C; Moliné T; Alvarez-Rios AM; Vidal M; Agraz I; Ordi-Ros J; Cortés-Hernández J
    Lupus; 2019 Mar; 28(3):396-405. PubMed ID: 30760090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
    Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
    J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.
    Ge YC; Jin B; Zeng CH; Zhang MC; Chen DC; Yin R; Le WB
    BMC Nephrol; 2016 Nov; 17(1):185. PubMed ID: 27876003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
    Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
    Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.